Euclidean Capital

Total investments

40

Average round size

72M

Portfolio companies

28

Rounds per year

2.67

Lead investments

3

Follow on index

0.30

Exits

2

Areas of investment
BiotechnologySoftwareFinTechArtificial IntelligenceMachine LearningHealth CareGeneticsMedical DeviceMedicalTherapeutics

Summary

The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is generally included in 2-6 deals every year. Comparing to the other companies, this Euclidean Capital performs on 16 percentage points less the average number of lead investments. The high activity for fund was in 2019. When the investment is from Euclidean Capital the average startup value is more than 1 billion dollars. The top amount of exits for fund were in 2019. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations.

The typical case for the fund is to invest in rounds with 7-8 participants. Despite the Euclidean Capital, startups are often financed by Polaris Partners, OrbiMed, GV. The meaningful sponsors for the fund in investment in the same round are Topspin Partners, The Column Group, Polaris Partners. In the next rounds fund is usually obtained by Viking Global Investors, Two Sigma Ventures, Topspin Partners.

The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are Biotechnology, SaaS. Among the most popular portfolio startups of the fund, we may highlight 23andMe, Alector, ArsenalBio. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

Besides them, we counted 2 critical employees of this fund in our database.

Show more

Investments analytics

Analytics

Total investments
40
Lead investments
3
Exits
2
Rounds per year
2.67
Follow on index
0.30
Investments by industry
  • Biotechnology (21)
  • Health Care (16)
  • Artificial Intelligence (9)
  • Medical Device (7)
  • Medical (6)
  • Show 43 more
Investments by region
  • United States (39)
  • Sweden (1)
Peak activity year
2021
Number of Unicorns
2
Number of Decacorns
2
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8
Avg. valuation at time of investment
147M
Group Appearance index
1.00
Strategy success index
0.50

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
April 29 Jun 2022 Financial Services, FinTech, Information Technology Early Stage Venture 30M United States, New York, New York
InduPro 13 Jun 2024 Early Stage Venture 85M United States, Washington, Seattle
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.